Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.

Source:http://linkedlifedata.com/resource/pubmed/id/20713706

Proc. Natl. Acad. Sci. U.S.A. 2010 Aug 31 107 35 15473-8

Download in:

View as

Triples

General Info

PMID
20713706